We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$604M
1-Year Est. Return
96.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.7%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$145M
AUM Growth
-$50.8M
(-26%)
Cap. Flow
-$35.6M
Cap. Flow
% of AUM
-24.58%
Top 10 Holdings %
Top 10 Hldgs %
65.8%
Holding
54
New
11
Increased
8
Reduced
13
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$7.45M |
| 2 |
Perrigo
PRGO
|
+$3.59M |
| 3 |
Medpace
MEDP
|
+$3.39M |
| 4 |
Philips
PHG
|
+$3.28M |
| 5 |
Actinium Pharmaceuticals
ATNM
|
+$2.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$14.8M |
| 2 |
NEOS
Neos Therapeutics, Inc
NEOS
|
+$7.86M |
| 3 |
Medtronic
MDT
|
+$6.51M |
| 4 |
Amgen
AMGN
|
+$6.09M |
| 5 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
+$5.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.94% |
| 2 | Miscellaneous | 28.58% |
| 3 | Industrials | 6.55% |
| 4 | Consumer Discretionary | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $17.1M | 11.79% |
54,642
-3,704
| -6% | -$1.04M |
|
|
2
CALL
Amgen
AMGN
$234B
| $15.2M | 10.5% |
91,300
+51,300
| +128% | +$8.67M |
|
|
3
Philips
PHG
$26.1B
| $13.7M | 9.44% |
624,852
+159,980
| +34% | +$3.28M |
|
4
Cardinal Health
CAH
$54.6B
| $10.4M | 7.18% |
133,937
-36,467
| -21% | -$2.95M |
|
5
Sanofi
SNY
$107B
| $8.53M | 5.88% |
223,380
+23,380
| +12% | +$938K |
|
|
TRHC
6
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $7.3M | 5.04% |
+510,000
| New | +$7.45M |
|
|
ATHN
7
PUT
DELISTED
Athenahealth, Inc.
ATHN
| $7.26M | 5.01% |
57,600
-25,500
| -31% | -$3.24M |
|
|
MDCO
8
CALL
DELISTED
Medicines Co
MDCO
| $6.78M | 4.68% |
+179,700
| New | +$6.77M |
|
9
PUT
Sarepta Therapeutics
SRPT
$2.2B
| $5.31M | 3.66% |
+86,500
| New | +$2.62M |
|
|
HRC
10
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $3.8M | 2.62% |
61,299
-22,301
| -27% | -$1.26M |
|
11
Rigel Pharmaceuticals
RIGL
$868M
| $3.75M | 2.58% |
102,072
-31,298
| -23% | -$897K |
|
|
CCXI
12
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.71M | 2.56% |
613,890
-28,938
| -5% | -$137K |
|
|
CERN
13
PUT
DELISTED
Cerner Corp
CERN
| $3.71M | 2.56% |
60,000
-170,000
| -74% | -$10.7M |
|
|
14
Perrigo
PRGO
$2.01B
| $3.6M | 2.48% |
+38,953
| New | +$3.59M |
|
|
15
Medpace
MEDP
$16.8B
| $3.46M | 2.39% |
+116,053
| New | +$3.39M |
|
16
PUT
AbbVie
ABBV
$451B
| $3.15M | 2.18% |
+50,000
| New | +$3.24M |
|
|
AAAP
17
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $2.88M | 1.98% |
75,557
-18,620
| -20% | -$620K |
|
|
ANTH
18
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $2.84M | 1.96% |
112,639
-204,307
| -64% | -$5.15M |
|
|
DMK
19
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $2.28M | 1.57% |
9,507
-271
| -3% | -$56.3K |
|
20
Ascendis Pharma A/S
ASND
$16.3B
| $2.26M | 1.56% |
112,497
-90,023
| -44% | -$1.49M |
|
|
NTUS
21
DELISTED
Natus Medical Inc
NTUS
| $2.2M | 1.52% |
+56,000
| New | +$2.23M |
|
|
ACET
22
DELISTED
Aceto Corp
ACET
| $2.2M | 1.52% |
+115,781
| New | +$2.62M |
|
|
23
Actinium Pharmaceuticals
ATNM
$31.7M
| $2.16M | 1.49% |
+53,333
| New | +$2.74M |
|
24
UnitedHealth
UNH
$353B
| $2.11M | 1.45% |
+15,049
| New | +$2.11M |
|
25
Coherus Oncology
CHRS
$218M
| $1.96M | 1.35% |
+73,053
| New | +$1.99M |
|
Similar funds
EFL
V
MAM
RCM
AMG
VV
VCP
EHI
Sio Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Sio Capital Management held 54 positions worth $145M, down 26% from $196M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Sio Capital Management withdrew a net $35.6M in Q3 2016, closing 22 positions and reducing 13 holdings. Its most notable exit was Biogen, an estimated $14.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 66% a quarter earlier, followed by Miscellaneous and Industrials.
Against the trend, Sio Capital Management opened a new position in Tabula Rasa HealthCare, Inc. Common Stock worth $7.3M.
- Sio Capital Management's largest Q3 2016 buy was Tabula Rasa HealthCare, Inc. Common Stock: 510,000 shares worth $7.3M.
- Sio Capital Management added most to Philips in Q3 2016, an estimated $3.28M increase.
- Sio Capital Management's biggest Q3 2016 reduction was Anthera Pharmaceuticals, Inc., cutting an estimated $5.15M.
- Sio Capital Management fully exited Biogen in Q3 2016, selling an estimated $14.8M.
- Sio Capital Management's ten largest holdings make up 66% of its $145M portfolio in Q3 2016.
- Sio Capital Management opened 11 new positions and closed 22 in Q3 2016.
- Sio Capital Management's portfolio value fell 26% quarter-over-quarter to $145M.
Based on Sio Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.